GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » PT Siloam International Hospitals Tbk (ISX:SILO) » Definitions » Research & Development

PT Siloam International Hospitals Tbk (ISX:SILO) Research & Development : Rp0 Mil (TTM As of Mar. 2024)


View and export this data going back to 2013. Start your Free Trial

What is PT Siloam International Hospitals Tbk Research & Development?

Research & Development is the aggregate amount of research and development expenses during the year. PT Siloam International Hospitals Tbk's Research & Development for the three months ended in Mar. 2024 was Rp0 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2024 was Rp0 Mil.


PT Siloam International Hospitals Tbk Research & Development Historical Data

The historical data trend for PT Siloam International Hospitals Tbk's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PT Siloam International Hospitals Tbk Research & Development Chart

PT Siloam International Hospitals Tbk Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

PT Siloam International Hospitals Tbk Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

PT Siloam International Hospitals Tbk Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was Rp0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


PT Siloam International Hospitals Tbk  (ISX:SILO) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.


PT Siloam International Hospitals Tbk Research & Development Related Terms

Thank you for viewing the detailed overview of PT Siloam International Hospitals Tbk's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.


PT Siloam International Hospitals Tbk (ISX:SILO) Business Description

Traded in Other Exchanges
Address
Jl. Boulevard Jend.Sudirman No. 15 Lippo Village, Fakultas Kedokteran Universitas Pelita Harapan, Lantai 32, Banten, Tangerang, IDN, 15810
PT Siloam International Hospitals Tbk operates a network of hospitals in Indonesia. The company manages and operates multiple hospitals in Jadebotabek. Siloam Hospitals makes investments in both technology and medical staff to offer a range of medical services. The company also manages Centers of Excellence that address medical cases requiring complex treatment. The company derives its revenue from inpatient and outpatient services. Inpatient services derive revenue from medical support and medical specialist services, drugs and medical supplies, and inpatient rooms. Outpatient services derive revenue from the delivery of medical support and medical specialist services; drugs and medical supplies; hospital facilities. Inpatient services are responsible for a majority of company revenue.